OroMed-Consulting: what changed
OroMed-Consulting
Largest movements
- Cash +€164,913
up €164,913 (+1,396%), from €11,810 to €176,724
mainly Net result for the year (+€186,030) and Current investments (+€54,509)
- Tangible fixed assets +€118,992
up €118,992 (+40.4%), from €294,182 to €413,174
- Current investments -€54,509
down €54,509 (-27.0%), from €202,138 to €147,629
- Receivables within one year -€29,564
down €29,564 (-35.9%), from €82,343 to €52,779
of which Trade receivables: -€28,336
- Reserves +€186,030
up €186,030 (+41.3%), from €450,014 to €636,043
of which Distributable reserves: +€186,030
- Tax, wage and social debts +€8,121
up €8,121 (+78.9%), from €10,293 to €18,414
- Other debts +€8,087
up €8,087 (+7.9%), from €102,849 to €110,936
- Gross operating margin +€43,451
up €43,451 (+21.1%), from €205,462 to €248,913
- Financial charges -€21,036
down €21,036 (-52.2%), from €40,307 to €19,271
- Taxes +€14,811
up €14,811 (+26.6%), from €55,622 to €70,433
- Financial income +€12,626
up €12,626 (+62.5%), from €20,204 to €32,830
- Other operating charges +€4,999
up €4,999 (+743%), from €673 to €5,672
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €591,201 | €792,791 | +€201,591 | +34.1% |
| Fixed assets | 21/28 | €294,182 | €413,174 | +€118,992 | +40.4% |
| Tangible fixed assets | 22/27 | €294,182 | €413,174 | +€118,992 | +40.4% |
| Furniture and vehicles | 24 | €294,182 | €413,174 | +€118,992 | +40.4% |
| Current assets | 29/58 | €297,018 | €379,617 | +€82,599 | +27.8% |
| Amounts receivable within one year | 40/41 | €82,343 | €52,779 | -€29,564 | -35.9% |
| Trade receivables | 40 | €81,115 | €52,779 | -€28,336 | -34.9% |
| Other amounts receivable | 41 | €1,228 | - | -€1,228 | |
| Current investments | 50/53 | €202,138 | €147,629 | -€54,509 | -27.0% |
| Cash at bank and in hand | 54/58 | €11,810 | €176,724 | +€164,913 | +1,396% |
| Deferred charges and accrued income | 490/1 | €728 | €2,486 | +€1,758 | +242% |
| Total equity and liabilities | 10/49 | €591,201 | €792,791 | +€201,591 | +34.1% |
| Equity | 10/15 | €468,614 | €654,643 | +€186,030 | +39.7% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €450,014 | €636,043 | +€186,030 | +41.3% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €448,154 | €634,183 | +€186,030 | +41.5% |
| Amounts payable | 17/49 | €122,587 | €138,148 | +€15,561 | +12.7% |
| Amounts payable within one year | 42/48 | €117,000 | €138,148 | +€21,148 | +18.1% |
| Trade debts | 44 | €3,859 | €8,798 | +€4,940 | +128% |
| Suppliers | 440/4 | €3,859 | €8,798 | +€4,940 | +128% |
| Taxes, remuneration and social security | 45 | €10,293 | €18,414 | +€8,121 | +78.9% |
| Taxes | 450/3 | €10,293 | €18,414 | +€8,121 | +78.9% |
| Other amounts payable | 47/48 | €102,849 | €110,936 | +€8,087 | +7.9% |
| Accrued charges and deferred income | 492/3 | €5,587 | - | -€5,587 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €574 | €336 | -€237 | -41.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €2,043 | - | -€2,043 | |
| Other operating charges | 640/8 | €673 | €5,672 | +€4,999 | +743% |
| Gross operating margin | 9900 | €205,462 | €248,913 | +€43,451 | +21.1% |
| Operating profit (loss) | 9901 | €202,172 | €242,904 | +€40,732 | +20.1% |
| Financial income | 75/76B | €20,204 | €32,830 | +€12,626 | +62.5% |
| Recurring financial income | 75 | €20,204 | €32,830 | +€12,626 | +62.5% |
| Financial charges | 65/66B | €40,307 | €19,271 | -€21,036 | -52.2% |
| Recurring financial charges | 65 | €40,307 | €19,271 | -€21,036 | -52.2% |
| Profit (loss) for the period before taxes | 9903 | €182,069 | €256,463 | +€74,394 | +40.9% |
| Income taxes | 67/77 | €55,622 | €70,433 | +€14,811 | +26.6% |
| Profit (loss) for the period | 9904 | €126,447 | €186,030 | +€59,583 | +47.1% |
| Profit (loss) for the period to be appropriated | 9905 | €126,447 | €186,030 | +€59,583 | +47.1% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.